Home/Filings/4/0000950170-24-115723
4//SEC Filing

Agarwal Vineet 4

Accession 0000950170-24-115723

CIK 0001703647other

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 7:43 PM ET

Size

29.5 KB

Accession

0000950170-24-115723

Insider Transaction Report

Form 4
Period: 2024-10-17
Agarwal Vineet
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-10-17$11.68/sh+9,263$108,1929,263 total
  • Sale

    Common Stock

    2024-10-17$78.59/sh457$35,9147,118 total
  • Sale

    Common Stock

    2024-10-17$79.79/sh1,815$144,8215,303 total
  • Sale

    Common Stock

    2024-10-17$73.71/sh164$12,0898,029 total
  • Sale

    Common Stock

    2024-10-17$76.00/sh56$4,2567,858 total
  • Sale

    Common Stock

    2024-10-17$82.89/sh25$2,0720 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-179,26331,607 total
    Exercise: $11.68Exp: 2031-05-29Common Stock (9,263 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-1795345,594 total
    Exercise: $14.98Exp: 2033-11-02Common Stock (953 underlying)
  • Sale

    Common Stock

    2024-10-17$77.00/sh23$1,7717,835 total
  • Sale

    Common Stock

    2024-10-17$80.50/sh4,961$399,374342 total
  • Sale

    Common Stock

    2024-10-17$81.48/sh317$25,82925 total
  • Exercise/Conversion

    Common Stock

    2024-10-17$14.98/sh+953$14,27610,216 total
  • Sale

    Common Stock

    2024-10-17$74.56/sh115$8,5757,914 total
  • Sale

    Common Stock

    2024-10-17$71.51/sh2,023$144,6638,193 total
  • Sale

    Common Stock

    2024-10-17$77.55/sh260$20,1647,575 total
Footnotes (11)
  • [F1]The reported transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 19, 2024.
  • [F10]The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
  • [F11]The shares subject to the option vest in 48 equal monthly installments commencing from November 3, 2023, subject to the Reporting Person's continued service on each such vesting date.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.965 to $71.94, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.30 to $73.975, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.51 to $74.90, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.01 to $78.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.07 to $78.935, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.12 to $80.115, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.15 to $81.14, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.20 to $82.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.

Documents

1 file

Issuer

Korro Bio, Inc.

CIK 0001703647

Entity typeother

Related Parties

1
  • filerCIK 0001997973

Filing Metadata

Form type
4
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 7:43 PM ET
Size
29.5 KB